Chelsea Nichols1, Ligia Maria Cruz Espinoza1, Vera von Kalckreuth1, Peter Aaby2, Muna Ahmed El Tayeb3, Mohammad Ali4, Abraham Aseffa5, Morten Bjerregaard-Andersen2, Robert F Breiman6, Leonard Cosmas7, John A Crump8, Denise Myriam Dekker9, Amy Gassama Sow10, Nagla Gasmelseed3, Julian T Hertz11, Justin Im1, Leon Parfait Kabore12, Karen H Keddy13, Frank Konings1, Sandra Valborg Løfberg2, Christian G Meyer14, Joel M Montgomery7, Aissatou Niang15, Andriamampionona Njariharinjakamampionona16, Beatrice Olack17, Gi Deok Pak1, Ursula Panzner1, Jin Kyung Park1, Se Eun Park1, Henintsoa Rabezanahary16, Jean Philibert Rakotondrainiarivelo16, Raphaël Rakotozandrindrainy16, Tiana Mirana Raminosoa16, Matthew P Rubach18, Mekonnen Teferi5, Hye Jin Seo1, Arvinda Sooka19, Abdramane Soura20, Adama Tall15, Trevor Toy1, Biruk Yeshitela5, John D Clemens21, Thomas F Wierzba1, Stephen Baker22, Florian Marks1. 1. International Vaccine Institute, Seoul, Republic of Korea. 2. Bandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark. 3. Faculty of Medicine, University of Gezira, Wad Medani, Sudan. 4. International Vaccine Institute, Seoul, Republic of Korea Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Armauer Hansen Research Institute, Addis Ababa, Ethiopia. 6. Kenya Medical Research Institute-Center for Global Health Research, Nairobi Global Health Institute, Emory University, Atlanta, Georgia. 7. Kenya Medical Research Institute-Center for Global Health Research, Nairobi Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention-Kenya, Nairobi. 8. Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina Centre for International Health, University of Otago, Dunedin, New Zealand Kilimanjaro Christian Medical Centre, Moshi, Tanzania. 9. Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. 10. Université Cheikh Anta Diop de Dakar Institut Pasteur de Dakar, Senegal. 11. Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina. 12. Schiphra Hospital, Ouagadougou, Burkina Faso. 13. National Institute for Communicable Diseases Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 14. Institute of Tropical Medicine, Eberhard-Karls University Tübingen, Germany. 15. Institut Pasteur de Dakar, Senegal. 16. University of Antananarivo, Madagascar. 17. Kenya Medical Research Institute-Center for Global Health Research, Nairobi. 18. Division of Infectious Diseases and International Health, Duke University Medical Center. 19. National Institute for Communicable Diseases. 20. Institut Supérieur des Sciences de la Population, University of Ouagadougou, Burkina Faso. 21. International Centre for Diarrheal Disease Research, Bangladesh, Dhaka UCLA Fielding School of Public Health. 22. Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Abstract
BACKGROUND: The clinical diagnosis of bacterial bloodstream infections (BSIs) in sub-Saharan Africa is routinely confused with malaria due to overlapping symptoms. The Typhoid Surveillance in Africa Program (TSAP) recruited febrile inpatients and outpatients of all ages using identical study procedures and enrollment criteria, thus providing an opportunity to assess disease etiology and pretreatment patterns among children and adults. METHODS: Inpatients and outpatients of all ages with tympanic or axillary temperatures of ≥38.0 or ≥37.5°C, respectively, and inpatients only reporting fever within the previous 72 hours were eligible for recruitment. All recruited patients had one blood sample drawn and cultured for microorganisms. Data from 11 TSAP surveillance sites in nine different countries were used in the analysis. Bivariate analysis was used to compare frequencies of pretreatment and BSIs in febrile children (<15 years old) and adults (≥15 years old) in each country. Pooled Cochran Mantel-Haenszel odds ratios (ORs) were calculated for overall trends. RESULTS: There was no significant difference in the odds of a culture-proven BSI between children and adults among inpatients or outpatients. Among both inpatients and outpatients, children had significantly higher odds of having a contaminated blood culture compared with adults. Using country-pooled data, child outpatients had 66% higher odds of having Salmonella Typhi in their bloodstream than adults (OR, 1.66; 95% confidence interval [CI], 1.01-2.73). Overall, inpatient children had 59% higher odds of pretreatment with analgesics in comparison to inpatient adults (OR, 1.59; 95% CI, 1.28-1.97). CONCLUSIONS: The proportion of patients with culture-proven BSIs in children compared with adults was similar across the TSAP study population; however, outpatient children were more likely to have Salmonella Typhi infections than outpatient adults. This finding points to the importance of including outpatient facilities in surveillance efforts, particularly for the surveillance of typhoid fever. Strategies to reduce contamination among pediatric blood cultures are needed across the continent to prevent the misdiagnosis of BSI cases in children.
BACKGROUND: The clinical diagnosis of bacterial bloodstream infections (BSIs) in sub-Saharan Africa is routinely confused with malaria due to overlapping symptoms. The Typhoid Surveillance in Africa Program (TSAP) recruited febrile inpatients and outpatients of all ages using identical study procedures and enrollment criteria, thus providing an opportunity to assess disease etiology and pretreatment patterns among children and adults. METHODS: Inpatients and outpatients of all ages with tympanic or axillary temperatures of ≥38.0 or ≥37.5°C, respectively, and inpatients only reporting fever within the previous 72 hours were eligible for recruitment. All recruited patients had one blood sample drawn and cultured for microorganisms. Data from 11 TSAP surveillance sites in nine different countries were used in the analysis. Bivariate analysis was used to compare frequencies of pretreatment and BSIs in febrile children (<15 years old) and adults (≥15 years old) in each country. Pooled Cochran Mantel-Haenszel odds ratios (ORs) were calculated for overall trends. RESULTS: There was no significant difference in the odds of a culture-proven BSI between children and adults among inpatients or outpatients. Among both inpatients and outpatients, children had significantly higher odds of having a contaminated blood culture compared with adults. Using country-pooled data, child outpatients had 66% higher odds of having Salmonella Typhi in their bloodstream than adults (OR, 1.66; 95% confidence interval [CI], 1.01-2.73). Overall, inpatient children had 59% higher odds of pretreatment with analgesics in comparison to inpatient adults (OR, 1.59; 95% CI, 1.28-1.97). CONCLUSIONS: The proportion of patients with culture-proven BSIs in children compared with adults was similar across the TSAP study population; however, outpatientchildren were more likely to have Salmonella Typhi infections than outpatient adults. This finding points to the importance of including outpatient facilities in surveillance efforts, particularly for the surveillance of typhoid fever. Strategies to reduce contamination among pediatric blood cultures are needed across the continent to prevent the misdiagnosis of BSI cases in children.
Authors: Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg Journal: Lancet Infect Dis Date: 2011-06-12 Impact factor: 25.071
Authors: Behzad Nadjm; George Mtove; Ben Amos; Naomi F Walker; Helmut Diefendal; Hugh Reyburn; Christopher J M Whitty Journal: Trans R Soc Trop Med Hyg Date: 2012-09-28 Impact factor: 2.184
Authors: R Passerini; D Riggio; D Radice; L Bava; C Cassatella; M Salvatici; L Zorzino; M T Sandri Journal: Eur J Clin Microbiol Infect Dis Date: 2008-07-29 Impact factor: 3.267
Authors: Behzad Nadjm; Ben Amos; George Mtove; Jan Ostermann; Semkini Chonya; Hannah Wangai; Juma Kimera; Walii Msuya; Frank Mtei; Denise Dekker; Rajabu Malahiyo; Raimos Olomi; John A Crump; Christopher J M Whitty; Hugh Reyburn Journal: BMJ Date: 2010-03-30
Authors: Julia Rhodes; Joseph A Hyder; Leonard F Peruski; Cindy Fisher; Possawat Jorakate; Anek Kaewpan; Surang Dejsirilert; Somsak Thamthitiwat; Sonja J Olsen; Scott F Dowell; Somrak Chantra; Kittisak Tanwisaid; Susan A Maloney; Henry C Baggett Journal: Am J Trop Med Hyg Date: 2010-08 Impact factor: 2.345
Authors: R Leon Ochiai; Camilo J Acosta; M Carolina Danovaro-Holliday; Dong Baiqing; Sujit K Bhattacharya; Magdarina D Agtini; Zulfiqar A Bhutta; Do Gia Canh; Mohammad Ali; Seonghye Shin; John Wain; Anne-Laure Page; M John Albert; Jeremy Farrar; Remon Abu-Elyazeed; Tikki Pang; Claudia M Galindo; Lorenz von Seidlein; John D Clemens Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408
Authors: A J Brent; I Ahmed; M Ndiritu; P Lewa; C Ngetsa; B Lowe; E Bauni; M English; J A Berkley; J A G Scott Journal: Lancet Date: 2006-02-11 Impact factor: 79.321
Authors: Alinune N Kabaghe; Benjamin J Visser; Rene Spijker; Kamija S Phiri; Martin P Grobusch; Michèle van Vugt Journal: Malar J Date: 2016-03-15 Impact factor: 2.979
Authors: Marina Antillón; Joshua L Warren; Forrest W Crawford; Daniel M Weinberger; Esra Kürüm; Gi Deok Pak; Florian Marks; Virginia E Pitzer Journal: PLoS Negl Trop Dis Date: 2017-02-27
Authors: Anneka M Hooft; Bryson Ndenga; Francis Mutuku; Victoria Otuka; Charles Ronga; Philip K Chebii; Priscillah W Maina; Zainab Jembe; Justin Lee; David M Vu; Dunstan Mukoko; A Desiree LaBeaud Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079
Authors: Duy Pham Thanh; Corinne N Thompson; Maia A Rabaa; Soeng Sona; Sun Sopheary; Varun Kumar; Catrin Moore; Nga Tran Vu Thieu; Lalith Wijedoru; Kathryn E Holt; Vanessa Wong; Derek Pickard; Guy E Thwaites; Nicholas Day; Gordon Dougan; Paul Turner; Christopher M Parry; Stephen Baker Journal: PLoS Negl Trop Dis Date: 2016-06-22